Abstract: The present invention provides a recombinant Vaccinia virus as a dengue virus vaccine that can be used as a therapeutic or prophylactic agent in the clinic. This recombinant Vaccinia virus is characterized by including: all or part of a cDNA that encodes a non-structural protein from a dengue virus; and an expression promoter.

Abstract: A battery system includes a battery block having a plurality of square battery cells (1) stacked in one direction, parallel connection bus bars (5X), insulating plate (7), and lid plate (8) fixed to insulating plate (7). Each square battery cell (1) has a discharge port provided with discharge valve (14) and a sealing plate provided with positive and negative electrode terminals via an insulating material. Parallel connection bus bars (5X) are connected to the electrode terminals to connect some or all of square battery cells (1) in parallel. Insulating plate (7) is disposed on the surfaces of sealing plates of the plurality of square battery cells (1) and includes passing portions having openings provided at positions corresponding to the discharge ports to pass the exhaust gas ejected from the discharge ports and pressing portions (22) disposed between parallel-connection bus bars (5X) and the sealing plates. Lid plate (8) faces discharge ports facing the openings of the passing portions.

Abstract: The present invention provides a recombinant Vaccinia virus as a dengue virus vaccine that can be used as a therapeutic or prophylactic agent in the clinic. This recombinant Vaccinia virus is characterized by including: all or part of a cDNA that encodes a non-structural protein from a dengue virus; and an expression promoter.

Abstract: [Problem to be solved] To provide a pharmaceutical composition for treating a disease caused by an RNA virus. [Solution] A pharmaceutical composition for a disease caused by an RNA virus or an inhibitor of RNA virus replication, comprising retinoic acid receptor responder protein 3 and/or an mTOR inhibitor.

Abstract: A battery system includes a battery block having a plurality of square battery cells (1) stacked in one direction, parallel connection bus bars (5X), insulating plate (7), and lid plate (8) fixed to insulating plate (7). Each square battery cell (1) has a discharge port provided with discharge valve (14) and a sealing plate provided with positive and negative electrode terminals via an insulating material. Parallel connection bus bars (5X) are connected to the electrode terminals to connect some or all of square battery cells (1) in parallel. Insulating plate (7) is disposed on the surfaces of sealing plates of the plurality of square battery cells (1) and includes passing portions having openings provided at positions corresponding to the discharge ports to pass the exhaust gas ejected from the discharge ports and pressing portions (22) disposed between parallel-connection bus bars (5X) and the sealing plates. Lid plate (8) faces discharge ports facing the openings of the passing portions.